Electronic signatures in regulated environments require human attribution. Here’s why AI agents must be architecturally blocked from signing, not just told not to.
A balanced analysis of how Veeva, Kivo, DnXT, and generic AI platforms approach AI in regulatory publishing — strengths and limitations of each.
A technical breakdown of four-layer tenant isolation in DnXT’s regulatory platform, and why it matters when AI agents interact with regulated data.
A technical look at how DnXT’s audit trail infrastructure handles AI-initiated actions while maintaining 21 CFR Part 11 and ALCOA+ data integrity standards.
How the Model Context Protocol enables AI agents to interact with GxP compliance systems while maintaining regulatory guardrails and audit integrity.
Test excerpt update at 2026-04-10T23:20:09.336Z
The Hidden Cost of Disconnected Regulatory Systems — And What Integration Actually Looks Like Walk into almost any mid-to-large pharma company’s regulatory department, and you’ll see a familiar sight: a collection of best-of-breed systems, each designed to do one thing well, but rarely speaking to each other. It’s a landscape I’ve navigated countless times in […]
We Built a Visual Workflow Engine for Pharma in 3 Weeks — Here’s the Architecture If you’ve spent any time in regulatory operations, you know the drill: critical processes like document reviews, submission approvals, and safety report routing often live in a chaotic mix of email chains, shared drives, and manual follow-ups. Or, if you’re […]
Why Health Authorities Are Watching How You Build Your eCTD — Not Just What You Submit If you’re still thinking of eCTD publishing as a “just make it valid” checkbox, you’re missing a critical shift in health authority expectations. The days of agencies simply validating your XML against a DTD and moving on are rapidly […]
From 5 Customers to 20+: What Scaling a Regulatory Tech Platform Actually Looks Like When we started DnXT, it wasn’t with a product in mind. It was with a deep understanding of regulatory operations, honed through years of consulting with global pharma companies, helping them navigate complex Veeva Vault implementations and optimize their processes. What […]
